GlassScriptPhysician profile
Kevin B Coppelson
NPI 1225322019
$2,841.80
in general payments reported to CMS, 2019-2025
12 companies · $899 in 2025
The $899 reported for 2025 was more than what 85% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.71 · 2021: $182 · 2022: $303 · 2023: $949 · 2024: $468 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788 · Travel and Lodging: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,787.81 |
| Travel and Lodging | $527.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $1,034.79 | 2021-2025 | |
| Patterson Companies, INC. | $540.64 | 2023 | |
| Depuy Synthes Sales INC. | $518.41 | 2024-2025 | Na, Trumatch |
| Nobel Biocare USA | $224.47 | 2020-2022 | |
| Acumed LLC | $143.29 | 2025 | Osteomed |
| Kerr Corporation | $115.84 | 2022 | |
| Medical Device Business Services, INC. | $97.31 | 2025 | Trumatch |
| Stryker Corporation | $47.39 | 2023-2025 | Vsp System, Vsp Cranial, Xpress Ent Dilation System |
| Pacira Pharmaceuticals Incorporated | $41.85 | 2024 | Exparel |
| Align Technology, INC. | $36.65 | 2020-2025 | Invisalign |
| Ormco Corporation | $20.71 | 2022 | |
| Aerin Medical INC. | $20.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Coppelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.